Medical Journals

Growth Hormone (Gh)-associated Nitration of Janus Kinase-2 at the 1007y-1008y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a Gh, Akt, and Nitric Oxide Synthase Axis on Gh Signal Transduction.

Authors:
  • Elsasser Ted H
  • Li Cong-Jun
  • Caperna Thomas J
  • Kahl Stanislaw
  • Schmidt Walter F

From: US Department of Agriculture, Agricultural Research Service, Growth Biology Laboratory, Beltsville, Maryland 20705, USA. elsasser@anri.barc.usda.gov

Endocrinology

  • Publish Date: Aug 2007
  • ISSN: 0013-7227
  • Volume: 148
  • Issue: 8
  • Pages: 3792-802
  • Medium: Print
  • Language: English
  • Citation (JAMA): Elsasser Ted H, Li Cong-Jun, Caperna Thomas J, et al. Growth Hormone (Gh)-associated Nitration of Janus Kinase-2 at the 1007y-1008y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a Gh, Akt, and Nitric Oxide Synthase Axis on Gh Signal Transduction.. Endocrinology Aug 2007;148:3792-802

Abstract

A generalized increase in liver protein tyrosine nitration (3’-nitrotyrosine, 3’-NT) occurs after GH injection in a time frame consistent with observed acute GH hyporesponsiveness. Here we investigated whether the GH-associated nitration process might be targeted to the (1007)Y-(1008)Y-phosphorylation epitope of Janus kinase (JAK)-2 because of its homology to a defined peptide nitration motif. Using antibodies we developed to the 3’NT-substituted peptide analog of the (1007)Y-(1008)Y-JAK2 site (nitro-JAK2), we demonstrated a rapid increase in membrane-associated nitro-JAK2 after GH. In vivo (bovine liver) and in vitro (porcine hepatocytes), GH-induced cellular levels of nitro-(1007)Y-(1008)Y-JAK2 persisted significantly longer after a stimulatory GH pulse than did levels of phospho-JAK2. Treatment of cultured cells with inhibitors of AKT or endothelial nitric oxide synthase prior to GH challenge attenuated the increases in nitro-JAK2 predominantly in the membrane subcellular fraction. In instances in which GH effected orthophosphorylation of (694)Y-signal transducer and activator of transcription (STAT)-5b, the addition of AKT and endothelial nitric oxide synthase inhibitors prior to GH significantly increased the levels of phospho-(694)Y-STAT5b and phospho-(1007)Y-JAK2 over those arising from GH alone. Nuclear magnetic resonance molecular modeling of natural and 3’-NT- and orthophosphate-substituted peptide analogs of the (1007)Y-(1008)Y site demonstrated significant effects of 3’-nitration on the planar orientation and intramolecular stabilizing points of the affected tyrosines. When these peptides were used as substrates for in vitro tyrosine kinase phosphorylation reactions, 3’-NT in the (1007)Y and/or (1008)Y positions blocked the generation of (1007)Y-phosphotyrosine. The data suggest that the nitration of JAK2 may act as an inhibitory counterpart to phosphorylation activation, reflecting a very localized break on the progression of GH signal transduction processes spanning JAK-STAT-AKT interactions.

Mesh Headings (Keywords): Animals, Binding Sites, Cattle, Cells, Cultured, Epitopes, Growth Hormone, Hepatocytes, Janus Kinase 2, Male, Nitrates, Nitric Oxide Synthase Type III, Phosphorylation, Protein Structure, Tertiary, Proto-Oncogene Proteins c-akt, Recombinant Proteins, Signal Transduction, Swine, Tyrosine


Check for Full Text / PubMed Unique Identifier (PMID): 17510232


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.